Heart inflammation more common after Covid than Pfizer vaccine: Study

Pfizer's Covid vaccine has been linked with an increased risk of developing myocarditis -- a type of heart inflammation.

Pfizer Vaccine, Coronavirus vaccine
Photo: Shutterstock
IANS New York
3 min read Last Updated : Aug 26 2021 | 3:02 PM IST

Pfizer's Covid vaccine has been linked with an increased risk of developing myocarditis -- a type of heart inflammation. But, the risk of the condition that can lead to heart failure, abnormal heartbeat and sudden death is more common after being infected with Covid-19, finds a large study that emphasises the need to get jabbed.

The study, published in the New England Journal of Medicine, showed that the Pfizer/BioNTech BNT162B2 vaccine against Covid-19 is safe. Out of 25 potential side effects examined, four were found to have a strong association with the vaccine.

Myocarditis was found to be associated with the vaccine, but rarely -- 2.7 excess cases per 1,00,000 vaccinated individuals. The myocarditis events observed after vaccination were concentrated in males between 20 and 34.

In contrast, coronavirus infection in unvaccinated individuals was associated with 11 excess cases of myocarditis per 1,00,000 infected individuals.

Other adverse events moderately associated with vaccination were swelling of the lymph nodes -- a mild side effect that is part of a standard immune response to vaccination -- with 78 excess cases per 1,00,000, appendicitis with 5 excess cases per 1,00,000 (potentially as a result of swelling of lymph nodes around the appendix), and herpes zoster with 16 excess cases per 1,00,000.

However, high rates of multiple serious adverse events were associated with coronavirus infection among unvaccinated patients, including: Cardiac arrhythmias (3.8-fold increase), kidney damage (14.8-fold increase), pericarditis (5.4-fold increase), pulmonary embolism (12.1-fold increase), deep vein thrombosis (3.8-fold increase), myocardial infarction (4.5-fold increase), and stroke (2.1-fold increase).

"These results show convincingly that this mRNA vaccine is very safe and that the alternative of 'natural' morbidity caused by the coronavirus puts a person at significant, higher and much more common risk of serious adverse events," said Professor Ran Balicer, Director of the Clalit Research Institute and Chief Innovation Officer for Clalit.

The study which provides reliable information on vaccine safety, may also help people with vaccine hesitancy.

"Those who have hesitated until now to get vaccinated due to concerns about very rare side effects -- such as myocarditis -- should be aware that the risks for this very same side effect are actually higher among unvaccinated infected individuals," Professor Ben Reis, Director of the Predictive Medicine Group at the Boston Children's and Harvard Medical School.

For the study, the team examined 8,84,828 vaccinated individuals aged 16 and over who were carefully matched with 8,84,828 unvaccinated individuals between December 20, 2020 and May 24, 2021.

--IANS

rvt/dpb

(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

Topics :PfizerCoronavirus VaccineVaccination

First Published: Aug 26 2021 | 3:02 PM IST

Next Story